Literature DB >> 20804346

Clinical findings, pain descriptions and physical complaints reported by women with post-natal pregnancy-related pelvic girdle pain.

Lars-Lennart Nielsen1.   

Abstract

The objective was to describe clinical findings and pain patterns following the provocation by activities of daily living (ADL) in women suffering from pregnancy-related post-natal pelvic pain 6-12 months after delivery. Forty-one informants answered questionnaires regarding pain characteristics in respect to 14 different ADL. All informants had bilateral pain, and typically it was described as an aching pain in the areas of the posterior superior iliac spines and in the symphyseal region. Running was the most provocative activity, followed by domestic work and by activities involving pushing and pulling. Duration of the activity had a great impact on the tolerance for all activities, and for the majority of the women, menstruation and ovulation caused an exacerbation of the symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20804346     DOI: 10.3109/00016349.2010.501853

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

Review 1.  Pelvic Girdle Pain during or after Pregnancy: a review of recent evidence and a clinical care path proposal.

Authors:  E H Verstraete; G Vanderstraeten; W Parewijck
Journal:  Facts Views Vis Obgyn       Date:  2013

2.  Nausea and vomiting in pregnancy - association with pelvic girdle pain during pregnancy and 4-6 months post-partum.

Authors:  Arthur Chortatos; Per Ole Iversen; Margaretha Haugen; Malin Eberhard-Gran; Elisabeth Krefting Bjelland; Marit B Veierød
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-08       Impact factor: 3.007

3.  Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study.

Authors:  Elisabeth Krefting Bjelland; Katrine Mari Owe; Hedvig Marie Egeland Nordeng; Bo Lars Engdahl; Per Kristiansson; Siri Vangen; Malin Eberhard-Gran
Journal:  PLoS One       Date:  2017-09-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.